NCT06581588View on ClinicalTrials.gov

Apneic Oxygenation by Transnasal Humidified Rapid Insufflation Ventilator Exchange Obstructive Sleep Apnea Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

April 13, 2025

Study Completion Date

April 13, 2025

Conditions

Obstructive Sleep Apnea Syndrome

Interventions

DEVICE

THRIVE

Device: Optiflow and THRIVE technique Nasal high flow humidified oxygen

DEVICE

THRIVE combine nasopharyngeal airway

Device: Optiflow and THRIVE technique Nasal high flow humidified oxygen and nasopharyngeal airway

Trial Locations (1)

100000

Beijing tongren Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

Beijing Tongren Hospital

OTHER

NCT06581588 - Apneic Oxygenation by Transnasal Humidified Rapid Insufflation Ventilator Exchange Obstructive Sleep Apnea Patients | Biotech Hunter | Biotech Hunter